Consistent. Controlled. Scalable.

The cell culture platform for diagnostic antibody developers, CDMOs running Rapid Tox, and CROs scaling transient CHO — as an outsourced service or in your lab.

Consistent Protein Manufacturing

Explore the Platform

$70B

lost annually to biologics scale-up inconsistency

3 in 4

drug rejections trace back to poor quality at scale

6-12 mnth

reduction in time to market with scale up efficiencies

MIT SHIP Finalist

~

The Engine Blueprint

~

BARDA Vanguard

~

MIT SHIP Finalist ~ The Engine Blueprint ~ BARDA Vanguard ~

WHO WE WORK WITH

Three segments. One platform. Find your path.

OUTSOURCED MANUFACTURING

Your antibody. Consistent lots. Every month.

We produce it on the EvoNode platform. You receive consistent material and ship it. No new infrastructure.

Commission your first run >

RAPID TOX PARTNERSHIP

Scale Rapid Tox without the manual workaround.

EvoNode's high-oxygen, low-shear architecture protects delicate bi-specific and multi-specific pools that standard platforms fail to support.

Explore a Rapid Tox partnership >

SCALING UP TRANSIENT EXPRESSION

Transient expresssion that actually scales

The first platform that makes transient CHO expression scale reliably, at a cost point built for CRO unit economics.

Run a Pilot >

How EvoNode eliminates the scale-up bottleneck.

Accessible

  • Under $150K total system

  • No specialized facilities required

  • Fits existing lab infrastructure

  • Minimal training needed

Simply Scalable

  • 250 mL → 10 L on same platform

  • Add capacity as you grow

  • No process transfer required

  • Predictable scale-up pathways

  • Full process control (pH, DO, DCO2)

  • Automated data logging

  • Single-use design prevents contamination

  • Proven bioprocessing principles

Reliable

  • Modular architecture grows with you

  • Upgrade path to clinical production

  • Investment protects long-term strategy

Future-Proof

Our Team: with 40+ years building the platforms biopharma runs on.

  • A young man with wavy, light-colored hair and a dark beard, wearing a dark blazer and a dark shirt, sitting in front of a bookshelf filled with books

    Ross Beighley

    Chief Executive Officer

    linkedin
  • Black and white photo of a man with glasses and a lab coat in a laboratory setting.

    Derek Troiano

    Chief Science Officer

    linkedin
  • Black and white portrait of a smiling man in a suit against a dark background.

    Roger Burton

    Chief Technology Officer

    linkedIn

Built to Win the Market We’re Opening

Protected Innovation

Patent-pending technology with expedited review status. Building a defensible moat that's 18-24 months ahead of the competition.

Industry Expertise

40+ years of combined experience from leading life science institutions. We've built the platforms that define the industry.

Elite Advisory Network

Advisory network from Asimov, Formation Ventures, PerkinElmer, and Open Biopharma spanning the full commercialization spectrum.

Recognized Innovation

BioTools Innovator (BARDA Vanguard) • MIT SHIP Finalist • The Engine Blueprint. Selected from 500+ applicants.

Explore the Opportunity

Ready to Scale Smarter?

Consistent biologics production without the infrastructure, capital commitment, or wait. Whether you run it or we do—results in weeks, not months.

Talk to the Team